文献速递瓣膜外科

生物瓣与机械瓣在主动脉瓣置换术中的长期结局比较

Biological versus mechanical prostheses for aortic valve replacement.
PubMed 文献 · J Thorac Cardiovasc Surg · 2021-02-05

该多中心观察性研究纳入2000至2018年间西班牙27家医院5215例50-65岁因重度孤立性主动脉瓣狭窄行主动脉瓣置换术的患者,随访15年。经2:1倾向评分匹配(机械瓣1822例,生物瓣911例)及竞争风险分析,两组长期生存无显著差异,机械瓣组大出血风险更高,生物瓣组再手术率更高。生物瓣在西班牙50-65岁患者中似乎是合理选择。

要点

  • 50-65岁患者行主动脉瓣置换,生物瓣与机械瓣长期生存相当。
  • 机械瓣大出血风险更高,生物瓣再手术率更高。
  • 生物瓣使用比例从2000-2008年的13%增至2009-2018年的24%。

核心结论

  • 50-65岁重度孤立性主动脉瓣狭窄患者中,生物瓣与机械瓣长期生存可比。
  • 机械瓣与更高的大出血风险相关,生物瓣与更高的再手术率相关。
  • 生物瓣在西班牙50-65岁患者中似乎是合理选择。

研究设计与样本

  • 多中心观察性研究,纳入2000至2018年西班牙27家医院50-65岁因重度孤立性主动脉瓣狭窄行主动脉瓣置换术的患者。
  • 共登记5215例患者,随访15年,采用多变量分析包括2:1倾向评分匹配(机械瓣1822例和生物瓣911例)及竞争风险分析。

主要发现

  • 生物瓣植入占19%(n=992)。

关键数值与推荐

  • 生物瓣使用比例从2000-2008年的13%增加至2009-2018年的24%。

临床怎么用

  • 对于50-65岁重度孤立性主动脉瓣狭窄患者,选择生物瓣或机械瓣需权衡大出血与再手术风险。
  • 生物瓣可作为该年龄段患者的合理选择,尤其关注出血风险时。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Long-term real-world outcomes are critical for informing decisions about biological (Bio) or mechanical (Mech) prostheses for aortic valve replacement, particularly in patients aged between 50 and 65 years. The objective was to compare long-term survival and major adverse cardiac and cardiovascular events (ie, stroke, reoperation, and major bleeding) within this population. METHODS: This was a multicenter observational study including all patients aged between 50 and 65 years who underwent an aortic valve replacement because of severe isolated aortic stenosis between the years 2000 and 2018. A total of 5215 patients from 27 Spanish hospitals were registered with a follow-up of 15 years. Multivariable analyses, including a 2:1 propensity score matching (1822 Mech and 911 Bio) and competing risks analyses were applied. RESULTS: Bio prostheses were implanted in 19% of patients (n = 992). No significant differences were observed between matched groups in long-term survival (hazard ratio [HR], 1.14; 95% confidence interval [CI], 0.88-1.47; P = .33). Stroke rates were higher for Mech prostheses, but not significant (HR, 0.72; 95% CI, 0.50-1.03; P = .07). Finally, higher rates of major bleeding were found in the Mech group (HR, 0.65; 95% CI, 0.49-0.87; P = .004), whereas reoperation was more frequent among the Bio group (HR, 3.04; 95% CI, 1.80-5.14; P < .001). Bio prostheses increased from 13% in the period from 2000 to 2008 to 24% in 2009 to 2018. CONCLUSIONS: Long-term survival was comparable among groups in patients between 50 and 65 years of age. Mech prostheses were associated with a higher risk of major bleeding, whereas Bio prostheses entailed higher reoperation rates. Bio prostheses seem a reasonable choice for patients between 50 and 65 years in Spain.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Rodríguez-Caulo EA, Blanco-Herrera OR, Berastegui E, et al. Biological versus mechanical prostheses for aortic valve replacement. J Thorac Cardiovasc Surg. 2021. PMID: 33712230. doi:10.1016/j.jtcvs.2021.01.118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。